ArticleACS pharmacology & translational science2023

Liposome-Based Silibinin for Mitigating Nonalcoholic Fatty Liver Disease: Dual Effects via Parenteral and Intestinal Routes.

Baofei Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.